These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

591 related articles for article (PubMed ID: 9351500)

  • 1. Cyclo-oxygenase isozymes in mucosal ulcergenic and functional responses following barrier disruption in rat stomachs.
    Hirata T; Ukawa H; Yamakuni H; Kato S; Takeuchi K
    Br J Pharmacol; 1997 Oct; 122(3):447-54. PubMed ID: 9351500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase isozymes involved in adaptive functional responses in rat stomach after barrier disruption.
    Takeeda M; Yamato M; Kato S; Takeuchi K
    J Pharmacol Exp Ther; 2003 Nov; 307(2):713-9. PubMed ID: 12975491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of endogenous prostaglandins and cyclooxygenase izoenzymes in mucosal defense of inflamed rat stomach.
    Takeeda M; Hayashi Y; Yamato M; Murakami M; Takeuchi K
    J Physiol Pharmacol; 2004 Mar; 55(1 Pt 2):193-205. PubMed ID: 15082878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of cyclooxygenase (COX)-2 products in acceleration of ulcer healing by gastrin and hepatocyte growth factor.
    Brzozowski T; Konturek PC; Konturek SJ; Pajdo R; Schuppan D; Drozdowicz D; Ptak A; Pawlik M; Nakamura T; Hahn EG
    J Physiol Pharmacol; 2000 Dec; 51(4 Pt 1):751-73. PubMed ID: 11192947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
    Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
    Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ulcerogenic influence of selective cyclooxygenase-2 inhibitors in the rat stomach with adjuvant-induced arthritis.
    Kato S; Ogawa Y; Kanatsu K; Okayama M; Watanabe T; Arakawa T; Takeuchi K
    J Pharmacol Exp Ther; 2002 Nov; 303(2):503-9. PubMed ID: 12388629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of cyclooxygenase-2 on formation and healing of acetic acid-induced gastric ulcer in rats].
    Shen X
    Zhonghua Yi Xue Za Zhi; 2001 Nov; 81(22):1380-3. PubMed ID: 11930633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased susceptibility of gastric mucosa to ulcerogenic stimulation in diabetic rats--role of capsaicin-sensitive sensory neurons.
    Tashima K; Korolkiewicz R; Kubomi M; Takeuchi K
    Br J Pharmacol; 1998 Aug; 124(7):1395-402. PubMed ID: 9723950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers.
    Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Pajdo R; Drozdowicz D; Ptak A; Hahn EG
    Microsc Res Tech; 2001 Jun; 53(5):343-53. PubMed ID: 11376495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal anti-inflammatory drugs and gastric mucosal responses.
    Takeuchi K; Suzuki K; Yamamoto H; Araki H; Mizoguchi H; Ukawa H
    J Physiol Pharmacol; 1998 Dec; 49(4):501-13. PubMed ID: 10069692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of cyclooxygenase-derived prostaglandin E2 and nitric oxide in the protection of rat pancreas afforded by low dose of lipopolysaccharide.
    Jaworek J; Bonior J; Tomaszewska R; Jachimczak B; Kot M; Bielański W; Pawlik WW; Sendur R; Stachura J; Konturek PC; Konturek SJ
    J Physiol Pharmacol; 2001 Mar; 52(1):107-26. PubMed ID: 11321505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective cyclo-oxygenase-2 inhibitors and their influence on the protective effect of a mild irritant in the rat stomach.
    Gretzer B; Ehrlich K; Maricic N; Lambrecht N; Respondek M; Peskar BM
    Br J Pharmacol; 1998 Mar; 123(5):927-35. PubMed ID: 9535022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rofecoxib produces intestinal but not gastric damage in the presence of a low dose of indomethacin in rats.
    Yokota A; Taniguchi M; Takahira Y; Tanaka A; Takeuchi K
    J Pharmacol Exp Ther; 2005 Jul; 314(1):302-9. PubMed ID: 15831440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adaptive gastric cytoprotection is mediated by prostaglandin EP1 receptors: a study using rats and knockout mice.
    Takeuchi K; Araki H; Umeda M; Komoike Y; Suzuki K
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1160-5. PubMed ID: 11356942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective cyclo-oxygenase-2 inhibitors aggravate ischaemia-reperfusion injury in the rat stomach.
    Maricic N; Ehrlich K; Gretzer B; Schuligoi R; Respondek M; Peskar BM
    Br J Pharmacol; 1999 Dec; 128(8):1659-66. PubMed ID: 10588920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of cyclooxygenase-2 in the healing of gastric ulcers in rats.
    Shigeta J; Takahashi S; Okabe S
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1383-90. PubMed ID: 9732401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of cyclooxygenase-2 in rat models of conjunctivitis.
    Oka T; Shearer T; Azuma M
    Curr Eye Res; 2004 Jul; 29(1):27-34. PubMed ID: 15370364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inducible types of cyclooxygenase and nitric oxide synthase in adaptive cytoprotection in rat stomachs.
    Yamamoto H; Tanaka A; Kunikata T; Hirata T; Kato S; Takeuchi K
    J Physiol Paris; 1999 Nov; 93(5):405-12. PubMed ID: 10674917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-inflammatory effect of two isoforms of COX in H. pylori-induced gastritis in mice: possible involvement of PGE2.
    Tanigawa T; Watanabe T; Hamaguchi M; Sasaki E; Tominaga K; Fujiwara Y; Oshitani N; Matsumoto T; Higuchi K; Arakawa T
    Am J Physiol Gastrointest Liver Physiol; 2004 Jan; 286(1):G148-56. PubMed ID: 12958020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of specific inhibition of cyclo-oxygenase-1 and cyclo-oxygenase-2 in the rat stomach with normal mucosa and after acid challenge.
    Gretzer B; Maricic N; Respondek M; Schuligoi R; Peskar BM
    Br J Pharmacol; 2001 Apr; 132(7):1565-73. PubMed ID: 11264251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.